One of the most recent studies out of Greece involved researchers looking into a vaporized weed formula with 13% CBD and 9% THC, and its effects on 69 patients with multiple sclerosis. The participants had varying symptoms, including muscle spasticity, bladder dysfunction, and disability progressions, all of which were analyzed at baseline levels to be evaluated again at three then six months. According to the researchers, “Significant improvement was observed across all outcome assessments,” after the patients were given vaporized weed.
Slapwoods is announcing its first-ever official collaboration with DJ Screw, the late Houston legend whose…
It could be so easy to believe that cannabis culture is something that has been…
Modern cultivation techniques and spiritual practices collide with Pink Boost Goddess on our next Legendary…
Animal rescuers and advocacy groups say dogs living on Skid Row are suffering from neglect,…
This article originally appeared in High Times’ 50th Anniversary print issue. It is an excerpt…
How Montana built a legal cannabis market from a thin medical marijuana law, federal raids,…